Stericycle (NASDAQ:SRCL) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Stericycle (NASDAQ:SRCL) in a research report released on Tuesday morning. The firm issued a hold rating on the business services provider’s stock.

Several other brokerages have also recently weighed in on SRCL. Royal Bank of Canada restated a sector perform rating and issued a $62.00 price target (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Truist Financial boosted their target price on shares of Stericycle from $50.00 to $62.00 and gave the company a hold rating in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods boosted their target price on shares of Stericycle from $135.00 to $142.00 and gave the company an outperform rating in a research note on Tuesday, June 4th. Finally, Robert W. Baird lowered their target price on shares of Stericycle from $62.00 to $55.00 and set a neutral rating for the company in a research note on Friday, April 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $74.00.

Stericycle Trading Down 0.2 %

Stericycle stock opened at $58.40 on Tuesday. The stock has a market cap of $5.42 billion, a P/E ratio of -265.45, a PEG ratio of 3.16 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11. Stericycle has a 1 year low of $37.78 and a 1 year high of $59.45. The firm’s 50 day moving average price is $56.12 and its 200-day moving average price is $51.95.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter in the previous year, the business posted $0.49 earnings per share. Stericycle’s quarterly revenue was down 2.8% on a year-over-year basis. On average, equities analysts predict that Stericycle will post 2.32 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stericycle

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in shares of Stericycle by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock valued at $444,509,000 after acquiring an additional 52,576 shares in the last quarter. Capital Research Global Investors increased its holdings in Stericycle by 11.4% in the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after buying an additional 679,974 shares during the period. Impax Asset Management Group plc boosted its position in Stericycle by 4.9% in the 4th quarter. Impax Asset Management Group plc now owns 3,139,032 shares of the business services provider’s stock worth $154,396,000 after purchasing an additional 147,452 shares in the last quarter. Earnest Partners LLC boosted its position in Stericycle by 12.4% in the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after purchasing an additional 271,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Stericycle by 10.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock worth $97,720,000 after purchasing an additional 192,045 shares in the last quarter. Institutional investors and hedge funds own 98.82% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.